A new way to carry gene blockers into brain tumor cells
Original title: An EGFR-Targeted Fusogenic Tandem Peptide for siRNA Delivery in Glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done in cells grown in a dish.
The short version
Researchers built a tiny carrier that slips a gene blocker into brain tumor cells in the lab.
What was studied. This was lab work in two glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary cell lines grown in a dish. The team tested a small peptide called GE11-599 to carry a gene blocker, siRNA, into those cells.
What they found. The peptide formed tiny particles that kept the gene blocker safe from being broken down. It helped the gene blocker get into the cells and escape the bubbles that usually trap it. Treated cells showed up to an 80% drop in STAT3 gene activity and a 40% drop in cell movement.
What this means, and what it doesn't
What it could mean: For a patient, this changes nothing today. It is an early step toward better ways to deliver gene blocking drugs to tumor cells.
What it doesn't mean: This was done only in cells in a dish. No people and no animals were treated. It is not a drug you can ask for, and it is not a cure. Much more testing would have to come first, over many years.
Source: PubMed, August 28, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.